Thousands of people die each year from hospital acquired infections (HAI) caused by antibiotic-resistant bacteria. Physicians could treat most infections successfully – even those caused by “superbugs” – if they could identify antibiotic resistance within a few hours of symptom onset. But bacterial culture usually takes one to three days – far too late to guide antibiotic therapy.
Our mission: to deliver bacterial identification and specific antibiotic susceptibility testing within 8 hours of specimen receipt. We're developing the BACcel™ system, a new analytical system that eliminates culturing to provide same-day results.
Related News: New Yorker article by Dr. Jerome Groopman, an excellent big-picture review of all of the emerging types of "superbugs" and the related medical issues. Printable link (free) ...
New Information: Journal publication describes photolithographic production of OptiChem® patterns for specific cell attachment and growth ... read more
News: Accelr8 Accelr8 Presents Research Results on Direct
Bacterial Extraction and “Superbug” Tests ... read more
News: Accelr8 and BD Sign Research and Licensing Option Agreement for Commercializing Accelr8's BACcel™ Rapid Diagnostics Technology
... read more
News: Accelr8 Announces Research Programs in Two Leading Medical Research Centers ... read more
New Information: IDSA Public Policy Statement (free PDF download) The Epidemic of Antibiotic-Resistant Infections (in Clinical Infectious Diseases, Jan 15, 2008)
News: BD Acquires Right to Negotiate Business Relationship for Accelr8's BACcel® Rapid Diagnostics Technology ... read more
News: Accelr8 Announces Sale of Two New Licenses for OptiChemŽ Surface Coatings ... read more
New Information: BACcel® System Backgrounder and BACcel® Q&A.